FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2013771801> ?p ?o ?g. }

• W2013771801 endingPage "644" @default.
• W2013771801 startingPage "639" @default.
• W2013771801 abstract "G protein-linked receptors are involved in the processes that lead to intimal hyperplasia. This study examined the role of Galphaq signaling pathways in vascular smooth muscle cell (SMC) proliferation in vitro.Rat pulmonary artery SMCs were cultured in vitro. Standard assays of cellular DNA synthesis, proliferation, phospholipase C-beta (PLCbeta) activation, and extracellular signal-regulated kinase (ERK1/2) phosphorylation were used to study the response to angiotensin II (a specific Galphaq agonist; 0.1-100 micromol/L) in the presence and absence of GP-2A (a competitive Galphaq inhibitor; 10 micromol/L) and the PLCbeta inhibitor U73122 (10micromol/L).Angiotensin II induced SMC DNA synthesis and cell proliferation. DNA synthesis was inhibited by both Galphaq inhibitor, GP-2A, and PLCbeta inhibitor U73122, in a dose-dependent manner (66% +/- 7% of angiotensin II alone at 10 micromol/L for GP-2A [P <.05] and 63% +/- 6% for U73122). GP-2A completely inhibited angiotensin II-induced Galphaq-mediated PLCbeta phosphorylation. Activation of ERK1/2 by angiotensin II was significantly reduced by GP-2A (P <.05) and by PLCbeta inhibition (P <.05).Inhibition of Galphaq decreases PLCbeta and ERK1/2 phosphorylation, leading to decreased SMC proliferation in vitro. Understanding specific signal transduction pathways will be an integral component of anti-restenosis therapy.Clinical Relevance The universal response of a blood vessel to injury is chronic wound healing, which includes the development of intimal hyperplasia and subsequent remodeling of the vessel wall. This can lead to luminal narrowing in as many as 30% of patients undergoing angioplasty. Neointimal formation is the principal cause of in-stent recurrent stenosis. Intimal hyperplasia is in part produced by smooth muscle cell (SMC) proliferation. Understanding the keys to the proliferation of SMCs will enable therapies to be developed that may inhibit the initial development of intimal hyperplasia. Whereas in the past many studies focused on the multiple mechanical, humoral, and cellular elements that induce SMC proliferation, molecular therapeutics focuses on key choke points within the cell that can be used to inhibit proliferation. One of these key choke points is signal transduction. Galphaq is one of the ubiquitous signal transduction proteins on the membrane of SMCs. Inhibiting G proteins, such as Galphaq, would enable interference with a significant amount of the mechanical, humeral, and cellular elements that produce SMC proliferation, and thus decrease the development of intimal hyperplasia. The present study identifies and begins to map out the role of Galphaq in SMC proliferation and investigates the possible use of a small peptide in its inhibition. Other data suggest that inhibition of other G proteins will also decrease intimal hyperplasia. This is therefore a fertile area for the development of therapeutics to inhibit intimal hyperplasia. The direct relevance to the clinician is that this study identifies a transduction pathway that may be inhibited, and points in the direction of a possible molecular therapeutic target that would be beneficial as an adjunct to angioplasty or as part of a drug-eluding stent regimen." @default.
• W2013771801 created "2016-06-24" @default.
• W2013771801 creator A5027120100 @default.
• W2013771801 creator A5049762785 @default.
• W2013771801 creator A5060668953 @default.
• W2013771801 creator A5061431909 @default.
• W2013771801 creator A5089155138 @default.
• W2013771801 date "2004-03-01" @default.
• W2013771801 modified "2023-10-16" @default.
• W2013771801 title "Role of Gαq in smooth muscle cell proliferation" @default.
• W2013771801 cites W1593673222 @default.
• W2013771801 cites W1606090338 @default.
• W2013771801 cites W1970677658 @default.
• W2013771801 cites W1987108104 @default.
• W2013771801 cites W1990581298 @default.
• W2013771801 cites W1992307459 @default.
• W2013771801 cites W1992425802 @default.
• W2013771801 cites W2034487226 @default.
• W2013771801 cites W2041977698 @default.
• W2013771801 cites W2046721533 @default.
• W2013771801 cites W2048527391 @default.
• W2013771801 cites W2055529568 @default.
• W2013771801 cites W2056702922 @default.
• W2013771801 cites W2060260328 @default.
• W2013771801 cites W2062940490 @default.
• W2013771801 cites W2071782926 @default.
• W2013771801 cites W2090231105 @default.
• W2013771801 cites W2094841666 @default.
• W2013771801 cites W2094848681 @default.
• W2013771801 cites W2095235443 @default.
• W2013771801 cites W2099736471 @default.
• W2013771801 cites W2134665522 @default.
• W2013771801 cites W2140975775 @default.
• W2013771801 cites W2153283433 @default.
• W2013771801 cites W2161952636 @default.
• W2013771801 cites W2335218877 @default.
• W2013771801 cites W2396628361 @default.
• W2013771801 doi "https://doi.org/10.1016/j.jvs.2003.10.052" @default.
• W2013771801 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/14981460" @default.
• W2013771801 hasPublicationYear "2004" @default.
• W2013771801 type Work @default.
• W2013771801 sameAs 2013771801 @default.
• W2013771801 citedByCount "19" @default.
• W2013771801 countsByYear W20137718012013 @default.
• W2013771801 countsByYear W20137718012014 @default.
• W2013771801 countsByYear W20137718012015 @default.
• W2013771801 countsByYear W20137718012016 @default.
• W2013771801 countsByYear W20137718012018 @default.
• W2013771801 countsByYear W20137718012019 @default.
• W2013771801 countsByYear W20137718012022 @default.
• W2013771801 crossrefType "journal-article" @default.
• W2013771801 hasAuthorship W2013771801A5027120100 @default.
• W2013771801 hasAuthorship W2013771801A5049762785 @default.
• W2013771801 hasAuthorship W2013771801A5060668953 @default.
• W2013771801 hasAuthorship W2013771801A5061431909 @default.
• W2013771801 hasAuthorship W2013771801A5089155138 @default.
• W2013771801 hasBestOaLocation W20137718011 @default.
• W2013771801 hasConcept C11960822 @default.
• W2013771801 hasConcept C126322002 @default.
• W2013771801 hasConcept C134018914 @default.
• W2013771801 hasConcept C170493617 @default.
• W2013771801 hasConcept C2775960820 @default.
• W2013771801 hasConcept C2778283817 @default.
• W2013771801 hasConcept C2778583881 @default.
• W2013771801 hasConcept C2778597717 @default.
• W2013771801 hasConcept C2778753947 @default.
• W2013771801 hasConcept C2779395532 @default.
• W2013771801 hasConcept C2779751240 @default.
• W2013771801 hasConcept C2780631158 @default.
• W2013771801 hasConcept C2908929049 @default.
• W2013771801 hasConcept C2992686903 @default.
• W2013771801 hasConcept C55493867 @default.
• W2013771801 hasConcept C57074206 @default.
• W2013771801 hasConcept C62112901 @default.
• W2013771801 hasConcept C62478195 @default.
• W2013771801 hasConcept C71924100 @default.
• W2013771801 hasConcept C86803240 @default.
• W2013771801 hasConcept C95444343 @default.
• W2013771801 hasConceptScore W2013771801C11960822 @default.
• W2013771801 hasConceptScore W2013771801C126322002 @default.
• W2013771801 hasConceptScore W2013771801C134018914 @default.
• W2013771801 hasConceptScore W2013771801C170493617 @default.
• W2013771801 hasConceptScore W2013771801C2775960820 @default.
• W2013771801 hasConceptScore W2013771801C2778283817 @default.
• W2013771801 hasConceptScore W2013771801C2778583881 @default.
• W2013771801 hasConceptScore W2013771801C2778597717 @default.
• W2013771801 hasConceptScore W2013771801C2778753947 @default.
• W2013771801 hasConceptScore W2013771801C2779395532 @default.
• W2013771801 hasConceptScore W2013771801C2779751240 @default.
• W2013771801 hasConceptScore W2013771801C2780631158 @default.
• W2013771801 hasConceptScore W2013771801C2908929049 @default.
• W2013771801 hasConceptScore W2013771801C2992686903 @default.
• W2013771801 hasConceptScore W2013771801C55493867 @default.
• W2013771801 hasConceptScore W2013771801C57074206 @default.
• W2013771801 hasConceptScore W2013771801C62112901 @default.
• W2013771801 hasConceptScore W2013771801C62478195 @default.
• W2013771801 hasConceptScore W2013771801C71924100 @default.
• W2013771801 hasConceptScore W2013771801C86803240 @default.

• next